Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China · Delayed Price · Currency is CNY 9.77
-0.35 (-3.46%)
Nov 13, 2026, 3:04 PM CST
SHE:002082 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 653.17 | 546.55 | 158.73 | 226.61 | 467.62 | 912.02 |
Short-Term Investments | - | - | 11.15 | - | - | - |
Cash & Short-Term Investments | 653.17 | 546.55 | 169.88 | 226.61 | 467.62 | 912.02 |
Cash Growth | 686.28% | 221.74% | -25.04% | -51.54% | -48.73% | 58.84% |
Accounts Receivable | 556.64 | 669.22 | 1,038 | 1,157 | 1,263 | 1,157 |
Other Receivables | 29.93 | 21.75 | 18.57 | 58.67 | 57.15 | 20.54 |
Receivables | 586.57 | 690.97 | 1,056 | 1,216 | 1,320 | 1,178 |
Inventory | 214.02 | 232.67 | 213.86 | 255.91 | 283.15 | 261.41 |
Prepaid Expenses | - | 2.63 | 5.58 | 3.31 | 4.46 | 4.13 |
Other Current Assets | 224.4 | 181.33 | 357.81 | 221.63 | 125.34 | 113.66 |
Total Current Assets | 1,678 | 1,654 | 1,803 | 1,923 | 2,201 | 2,469 |
Property, Plant & Equipment | 1,540 | 1,559 | 1,564 | 1,495 | 1,274 | 1,175 |
Long-Term Investments | 20.63 | 122.53 | 112.08 | 10.52 | 12.35 | 12.91 |
Goodwill | 127.82 | 128.86 | 125.67 | 125.46 | 127.93 | 194.79 |
Other Intangible Assets | 609.84 | 581.4 | 461.79 | 418.46 | 430.97 | 398.65 |
Long-Term Accounts Receivable | 14.78 | 15.23 | 14.06 | 12.79 | 6.57 | 3.97 |
Long-Term Deferred Tax Assets | 145.18 | 137.03 | 134.44 | 113.62 | 90.54 | 54.23 |
Long-Term Deferred Charges | 99.86 | 93.9 | 63.04 | 58.5 | 30.2 | 23.52 |
Other Long-Term Assets | 72.52 | 99.59 | 48.91 | 138.69 | 44.47 | 39.06 |
Total Assets | 4,308 | 4,391 | 4,327 | 4,296 | 4,218 | 4,371 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 298.44 | 339.46 | 247.36 | 302.55 | 231.18 | 254.51 |
Accrued Expenses | 29.18 | 63.28 | 67.33 | 73.08 | 63.79 | 95.99 |
Short-Term Debt | 631 | 650.86 | 855.17 | 825.43 | 677.96 | 572.21 |
Current Portion of Long-Term Debt | 109.59 | 27.14 | 54.19 | 54.27 | 37.28 | 31.5 |
Current Portion of Leases | - | 144.67 | 3.24 | 2.65 | 0.55 | 0.54 |
Current Income Taxes Payable | 29.05 | 10.23 | 18.13 | 17.34 | 24.6 | 190.25 |
Current Unearned Revenue | 53.79 | 35.21 | 16.82 | 14.31 | 30.28 | 33.21 |
Other Current Liabilities | 149.66 | 79.84 | 54.02 | 36.98 | 71.61 | 105.19 |
Total Current Liabilities | 1,301 | 1,351 | 1,316 | 1,327 | 1,137 | 1,283 |
Long-Term Debt | 179.56 | 172.7 | 104 | 81.51 | 135.2 | 237 |
Long-Term Leases | 73.66 | 119.58 | 11.61 | 11.99 | 13.43 | 1.22 |
Long-Term Unearned Revenue | 91.36 | 91.05 | 92.18 | 70.54 | 68.06 | 59.37 |
Long-Term Deferred Tax Liabilities | 42.65 | 45.37 | 44.21 | 40.83 | 39.36 | 33.5 |
Other Long-Term Liabilities | 3.67 | 4.27 | 2.68 | 5.91 | 6.48 | 12.19 |
Total Liabilities | 1,692 | 1,784 | 1,571 | 1,537 | 1,400 | 1,627 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 611.69 | 611.69 | 616.69 | 616.69 | 618.22 | 618.22 |
Additional Paid-In Capital | 257.93 | 257.93 | 311.78 | 311.78 | 305.79 | 305.79 |
Retained Earnings | 1,685 | 1,659 | 1,827 | 1,820 | 1,844 | 1,751 |
Treasury Stock | - | - | -59.99 | -59.99 | -59.99 | -50.96 |
Comprehensive Income & Other | -16.9 | -13.13 | -28.34 | -30.92 | -21 | -25.88 |
Total Common Equity | 2,537 | 2,516 | 2,667 | 2,658 | 2,687 | 2,598 |
Minority Interest | 79.35 | 91.66 | 89.64 | 101.28 | 131.02 | 146.33 |
Shareholders' Equity | 2,617 | 2,608 | 2,756 | 2,759 | 2,818 | 2,745 |
Total Liabilities & Equity | 4,308 | 4,391 | 4,327 | 4,296 | 4,218 | 4,371 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 993.8 | 1,115 | 1,028 | 975.84 | 864.42 | 842.48 |
Net Cash (Debt) | -340.64 | -568.4 | -858.34 | -749.23 | -396.8 | 69.54 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.46 | -0.92 | -1.39 | -1.22 | -0.64 | 0.11 |
Filing Date Shares Outstanding | 611.69 | 611.69 | 611.69 | 611.69 | 613.22 | 614.08 |
Total Common Shares Outstanding | 611.69 | 611.69 | 611.69 | 611.69 | 613.22 | 614.08 |
Working Capital | 377.44 | 303.45 | 487.05 | 596.66 | 1,064 | 1,185 |
Book Value Per Share | 4.15 | 4.11 | 4.36 | 4.34 | 4.38 | 4.23 |
Tangible Book Value | 1,800 | 1,806 | 2,079 | 2,114 | 2,128 | 2,005 |
Tangible Book Value Per Share | 2.94 | 2.95 | 3.40 | 3.46 | 3.47 | 3.26 |
Buildings | - | 895.4 | 893.08 | 700.33 | 577.02 | 530.22 |
Machinery | - | 777.69 | 777.07 | 703.7 | 679.8 | 668.65 |
Construction In Progress | - | 586.04 | 510.85 | 611.33 | 472.39 | 380.88 |